It is our goal in this study to compare the outcomes of laparoscopic cholecystectomy with
CBD exploration against laparoscopic exploration of CBD using intraoperative endoscopic
retrograde cholangiopancreatography (ERCP). Single-stage procedures may reduce the time
of hospital stay as a result of advances in technique and more expertise in the area of
minimally invasive surgery. We have two groups of people to consider: A total of 120
individuals with gall bladder and CBD stones participated in this trial. All patients had
laparoscopic cholecystectomy, and then intraoperative ERCP was used to cure CBD stones in
60 patients; the remaining 60 patients were treated with LCBDE (B). A six-month follow-up
was required. In the end, there was no fatality. Group B's operating duration was substantially
longer (2.98 hours); the P value for this difference was 0.001. As for conversion, there were
no significant changes (P = 0.20). Group A had a considerably lower rate of haemorrhage and
collection than group B (P 0.001). Group B had no pancreatic duct damage; the P value was
0.006. P values of 0.07 and 0.2 for penetration and recurrence of stones were found in both
groups, however CBD Stricture was significantly higher in group B; P value, 0.005. The
conclusion is that both techniques can be employed to treat CBD stones. The less intrusive
intraoperative ERCP is, the less time it takes, the less blood it requires, the shorter the
hospital stay, and the less likely it is to cause postoperative CBD stricture.